Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human TDP43 ELISA Kit (AC3036)
Cat.#: ASET-1625
Specifications
Description Human TDP43 ELISA Kit allows for the in vitro quantitative determination of human TDP43 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.188 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.313-20 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1926 Porcine Neurotrophin 3 ELISA Kit (AC3337) Quantitative inquiry ASET-1390 Mouse Clathrin Light Chain ELISA Kit (AC2801) Quantitative inquiry ASET-2486 Human Doublecortin ELISA Kit (AC3897) Quantitative inquiry ASET-1060 Mouse Homer1 ELISA Kit (AC2471) Quantitative inquiry ASET-2477 Porcine Slit2 ELISA Kit (AC3888) Quantitative inquiry ASET-1591 Mouse IL-6 ELISA Kit (AC3002) Quantitative inquiry ASET-1048 Human Profilin 1 ELISA Kit (AC2459) Quantitative inquiry ASET-2531 Rat Tyrosine Hydroxylase ELISA Kit (AC3942) Quantitative inquiry ASET-2265 Mouse Hes1 ELISA Kit (AC3676) Quantitative inquiry ASET-1233 Human TAS2R38 ELISA Kit (AC2644) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket